Therapeutic development of group B Streptococcus meningitis by targeting a host cell signaling network involving EGFR is a research paper published in EMBO Molecular Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: NS091102
HHS | National Institutes of Health
Grant: AI84984
HHS | National Institutes of Health
Grant: AI113273
HHS | National Institutes of Health
Grant: AI126176
NIAID NIH HHS
Grant: R21 AI126176
NINDS NIH HHS
Grant: R01 NS091102
NIAID NIH HHS
Grant: R21 AI113273
NIAID NIH HHS
Grant: R01 AI084984
National Institutes of Health
Grant: 5R21AI113273-02
E. coli penetration of the blood-brain barrier
National Institutes of Health
Grant: 5R21AI126176-02
Pathogenesis of bacterial meningitis
National Institutes of Health
Grant: 5R01AI084984-05
Leukotrienes and blood-brain barrier
National Institutes of Health
Grant: 5R01NS091102-04
Host factors and bacterial meningitis
FWCI
1.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals